How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2020-09, Vol.20, p.S8-S11
Main Authors: Gupta, Sumit, Maude, Shannon L., O'Brien, Maureen M., Rau, Rachel E., McNeer, Jennifer L.
Format: Article
Language:English
Subjects:
Adolescent
Antineoplastic Agents, Immunological - therapeutic use
B-ALL
blinatumomab
Child
children
Humans
Immunotherapy - methods
inotuzumab ozogamicin
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Risk Factors
tisagenlecleucel
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/S2152-2650(20)30443-2